Open access
Sep 2026
Tri-modal PSMA PET/CT-MRI-US fusion biopsy for clinically significant prostate cancer: a prospective paired diagnostic study
Tri-modal fusion was superior to MRI-US fusion biopsy in detecting csPCa, particularly in small PSMA-positive and PI-RADS 4 lesions, and multicenter validation before clinical adoption.
Chen Huang, Li-Chen Jin, Yi-Zhang Sun et al.
· European Journal of Nuclear... · 0 citations